ClinicalTrials.gg
Not yet recruitingNCT06089629Updated Apr 3, 2024

Frenuloplasty for Speech and Myofunctional Outcomes

An interventional study of Lingual frenuloplasty in Ankyloglossia, Speech Delay and Dentofacial Abnormalities, sponsored by The Oregon Clinic. Not yet recruiting. Open to participants aged 5 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-03.

Sponsored by The Oregon Clinic · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Apr 2025, 1 year 7 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
5 Years to 12 Years
Sex
All
01

Study summary

Children with ankyloglossia (tongue tie) can have abnormal tongue function, putting them at a disadvantage when it comes to speech and articulation. Furthermore, abnormal tongue posture within the oral cavity increases the likelihood of myofunctional disorders.

Read the detailed description

The current body of literature surrounding ankyloglossia and speed delay is mixed. The literature base is riddled with retrospective reviews, poor descriptions of surgical intervention, and the lack of standardized grading schemes with respect to articulation. Furthermore, the candidacy for intervention in these instances only involves children with anterior tongue tie. There is a complete lack of investigation surrounding the impact of posterior tongue tie on articulation.

The other area that has inadequately been studied is the impact ankyloglossia has on myofunctional outcomes. There are data now that demonstrate how ankyloglossia is correlated with a vaulted palate and has long term orthodontic consequences. This study aims to demonstrate how release of posterior tongue tie improves lingual strength and posture.

02

Conditions studied

  • Ankyloglossia
  • Speech Delay
  • Dentofacial Abnormalities

Keywords

  • ankyloglossia
  • speech delay
  • myofunctional therapy
  • dentofacial abnormalities
03

In context

Ankyloglossia

32 studies on the registry are indexed under Ankyloglossia; 8 are open to participants now.

This study's planned enrollment of 50 is below the median of 105 across 22 interventional studies indexed under Ankyloglossia.

Browse Ankyloglossia studies →

Lead sponsor

The Oregon Clinic is the lead sponsor of 11 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children ages 5-12 with posterior tongue tie who are undergoing treatment just for ankyloglossia
  • Children must already be working with an SLP who has done a speech and myofunctional evaluation

Exclusion criteria

Exclusion Criteria:

  • Children undergoing other procedures at the same time as the frenuloplasty (tonsillectomy, adenoidectomy, etc)
  • Significant medical comorbidities (cardiovascular, neurological, etc)
  • Anterior tongue tie or lip tie
  • Previous lingual surgery
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • No intervention
    Control group

    Nonsurgical intervention with speech and myofunctional therapy

  • Experimental
    Intervention group

    Surgical intervention with frenuloplasty followed by speech and myofunctional therapy

    Procedure: Lingual frenuloplasty

Interventions

  • ProcedureLingual frenuloplasty

    Surgical release of ankyloglossia with suture reorientation of the wound to improve lingual mobility, done under local or general anesthesia

06

What researchers measure

Primary outcomes

  1. Speech/Articulation

    Using the GFTA-3 test of articulation

    Time frame: Baseline (timepoint 0) and 2 months post-intervention (surgical group) or 2 months post-therapy alone (control group)

  2. Tongue mobility

    Using the TRMR grading scale

    Time frame: Baseline (timepoint 0) and 2 months post-intervention (surgical group) or 2 months post-therapy alone (control group)

  3. Tongue strength

    Using the IOPI instrument

    Time frame: Baseline (timepoint 0) and 2 months post-intervention (surgical group) or 2 months post-therapy alone (control group)

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jul 2024; primary completion for Apr 2025, 9 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 8, 2023
First posted
Oct 18, 2023
StartEst.
Jul 1, 2024
Primary completionEst.
Apr 1, 2025
CompletionEst.
Dec 1, 2025
Last update
Apr 3, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 3, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06089629
Lead sponsor
The Oregon Clinic
Responsible party
Bobak Ghaheri, MD (Otolaryngologist, The Oregon Clinic) — Principal investigator
First posted
Oct 18, 2023
Start date
Jul 1, 2024 (estimated)
Primary completion
Apr 1, 2025 (estimated)
Completion
Dec 1, 2025 (estimated)
Last update
Apr 3, 2024

Study contacts

Bobak Ghaheri, MD
Contact
drghaheri@gmail.com
5034882600

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion